Yan Wang
FDA investigator
Appears on 2 documents from 2018 to 2022, mostly at sites in India. Most often cites control of microbiological contamination (21 CFR 211.113).
- 2
- Documents on file
- 6.5
- Observations per 483
- 2018
- First seen
- 2022
- Most recent
What they cite most
From 3 observations- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.42Design and construction features1
Activity by year
2018: 1, 2022: 1
Where
India 1 · New Jersey 1
Often inspects with
Is Yan Wang coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2022-10-14 | 483 Lupin Limited (Biotech Division)Oct 14, 2022 · Pune, India | Pune, India | 11 | |
| 2018-03-09 | 483 ImClone Systems LLCMar 9, 2018 · Branchburg, New Jersey | Branchburg, New Jersey | 2 |
About this profile
What does Yan Wang inspect?
Yan Wang appears on 2 documents on file covering 2 sites, mostly in India.
What do they cite most often?
21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.42.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Yan Wang is dated Oct 14, 2022.